We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Endurance & exercise performanceRapid ketone body production provides alternative fuel during exercise · 30-60 minutes
Too few graded studies2 studies
Energy & fatigueQuick, sustained energy from ketone production · 30-60 minutes
Too few graded studies1 study
Digestive health
Too few graded studies1 study
Safety profile
Too few graded studies1 study
By the numbers
Pulled from 17 studies with measurable effects
People studied
2,887
typical study: 52 people
Strongest designs
23
11 pooled, 12 randomised
Showed benefit
100%
2/2 studies
How long studies ran
1–4 weeks
1
1–3 months
1
3+ months
2
Populations Studied
People with neurodegenerative disease1
Adults with disease1
Children with drug-resistant epilepsy1
General population1
Active research area
23 studies in the last 5 years · Latest meta-analysis: 2024
200420152026
1Neurodegenerative disease managementSystematic ReviewCited 18×n=979 · large study2021
Overall, 3/17 studies carried a low risk of bias.
Dewsbury LS et al. · Advances in nutrition (Bethesda, Md.) (2021)
Overall, 3/17 studies carried a low risk of bias.
Based on available evidence, exogenous ketogenic agents may be more feasible than dietary interventions in NDD from a compliance and adherence perspective; more research is required to confirm this.
2Clinical benefits of exogenous ketosisSystematic ReviewCited 4×2025
Exogenous ketosis shows potential in neurological, metabolic, and cardiovascular disorders, while evidence in psychiatric and inflammatory conditions remains scarce and preliminary.
Mohib O et al. · Nutrients (2025)
Exogenous ketosis shows potential in neurological, metabolic, and cardiovascular disorders, while evidence in psychiatric and inflammatory conditions remains scarce and preliminary.
Ketone esters appear preferable for effective and tolerable ketosis.
Future research should focus on identifying responsive patient populations, optimizing treatment regimens, and conducting long-term clinical trials with hard endpoints to validate these findings.
3AMPA receptor modulation through MCTs in pediatric epilepsySystematic ReviewCited 1×2025
The summarized findings reinforce the therapeutic potential of MCTs, highlighting both the beneficial seizure outcomes and the hurdles that remain to be addressed through future research.
Falsaperla R et al. · Nutrients (2025)
Methods: A systematic review was conducted, including articles from January 2000 to January 2025, to explore the potential role of medium-chain triglyceride (MCT) add-on to classic KD and as MCT supplementation in free diets in the management of pediatric drug-resistant epilepsy (DRE).
Results: Selected studies show how the action of MCTs, and decanoic acid in particular, is via negative modulation of AMPA receptors, with a positive impact on epileptic seizures.
Conclusions: This review discusses the complexities of implementing and sustaining KD in children and presents recent pre-clinical and clinical evidence, including trials where MCTs (often enriched in decanoic acid) serve as an add-on therapy in both ketogenic and free/unrestricted diets.
Limitations include heterogeneous intervention conditions, such as different types of dispersions, caffeine intake, limited number of studies and variability in study design.
Frenser M et al. · Nutrients (2024)
Forest plot analysis showed heterogeneous data.
The data suggest a non-linear relationship between C8, carbohydrate intake and ketone production.
Further studies are needed to investigate the influence of different carbohydrates on C8-induced ketogenesis.
7Weight loss and metabolic healthMeta-AnalysisCited 8×2024
Hence, the authors recommend incorporating pure MCTs in dietary interventions for individuals with overweight and obesity, particularly those with comorbidities such as dyslipidemia and impaired glucose metabolism.
He H et al. · Clinical nutrition (Edinburgh, Scotland) (2024)
However, our subgroup analysis indicates that an MLCTs-enriched diet did not significantly reduce weight loss.
Additionally, MCTs-enriched diets were associated with significant reductions in blood triglyceride levels and Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) scores, compared to LCTs-enriched diets.
Hence, the authors recommend incorporating pure MCTs in dietary interventions for individuals with overweight and obesity, particularly those with comorbidities such as dyslipidemia and impaired glucose metabolism.
In this meta-analysis, we demonstrated that MCTs can induce mild ketosis and may improve cognition in patients with mild cognitive impairment and Alzheimer's disease.
Avgerinos KI et al. · Ageing research reviews (2020)
In this meta-analysis, we demonstrated that MCTs can induce mild ketosis and may improve cognition in patients with mild cognitive impairment and Alzheimer's disease.
However, risk of bias of existing studies necessitates future trials.
MCT supplementation may enhance working memory in non-demented older adults.
Giannos P et al. · BMC geriatrics (2022)
MCT supplementation may enhance working memory in non-demented older adults.
These effects may be more prominent in individuals with lower baseline scores, from short and long-term supplementation.
Further studies are warranted to confirm these findings in terms of optimal dose and MCTs composition, which may protect from memory decline during aging.
Although animal studies indicate promising results, research on the effect of ketogenic therapy in PD is still in its infancy, with RCTs conducted on humans being heterogeneous and lacking PD-specific outcomes.
Grammatikopoulou MG et al. · Maturitas (2022)
Although animal studies indicate promising results, research on the effect of ketogenic therapy in PD is still in its infancy, with RCTs conducted on humans being heterogeneous and lacking PD-specific outcomes.
More studies are required to recommend or refute the use of ketogenic therapy in PD.
12Meta-AnalysisCited 55×n=27 · very small study2016
These findings indicate that the magnitude of the increase in DIT is influenced by the energy intake, macronutrient composition, and eating pattern of the meal.
Quatela A et al. · Nutrients (2016)
Meals with medium chain triglycerides had a significantly higher DIT than long chain triglycerides (meta-analysis, p = 0.002).
Consuming the same meal as a single bolus eating event compared to multiple small meals or snacks was associated with a significantly higher DIT (meta-analysis, p = 0.02).
Unclear or inconsistent findings were found by comparing the consumption of meals quickly or slowly, and palatability was not significantly associated with DIT.
14General cognitive functionMeta-AnalysisCited 9×n=10 · very small study2023
This review provides some evidence that treatment with MCT could improve general cognitive function in APOEɛ4 (-) cognitive impaired patients.
Sun L et al. · Journal of Alzheimer's disease : JAD (2023)
Large benefit
← WorseNo effectBetter →
Meta-analysis showed cognitive improvements in general (SMD = 0.64; 95% CI [0.05, 1.24]), but not in memory, language, and attention domains after oral MCT administration, compared to placebo.
The effect of MCT was greater among APOEɛ4 (-) subjects than APOEɛ4 (+) subjects (SMD = 1.87; 95% CI [0.35, 3.40]).
This review provides some evidence that treatment with MCT could improve general cognitive function in APOEɛ4 (-) cognitive impaired patients.
Despite statistically significant results, the recommendation to replace dietary LCTs with MCTs must be cautiously taken, because the available evidence is not of the highest quality.
Bueno NB et al. · Journal of the American College of Nutrition (2015)
Despite statistically significant results, the recommendation to replace dietary LCTs with MCTs must be cautiously taken, because the available evidence is not of the highest quality.
16MCT clinical applications and regulatory frameworksSystematic Review2026
This review integrates knowledge on MCT metabolism, industrial production, clinical applications, and regulatory frameworks in Germany, Japan, and the United States, highlighting how regulatory environments influence the translation of MCTs from clinical nutrition toward broader preventive health strategies.
Heidt C et al. · Nutrients (2026)
In Germany and across the European Union, they are primarily used in Foods for Special Medical Purposes (FSMPs) for conditions such as fat malabsorption, ketogenic dietary therapy for refractory epilepsy, and inherited disorders of long-chain fatty-acid oxidation.
In Japan, MCTs are additionally incorporated into functional food systems, including Foods for Specified Health Uses (FOSHU) and Foods with Function Claims (FFC), targeting generally healthy adults and older populations.
In the United States, MCTs are widely marketed as food ingredients, dietary supplements, clinical nutrition products, and medical foods, reflecting their status as generally recognized as safe (GRAS).
Nutritional biomarkers appear to influence cognitive trajectories in MCI, and some associations may differ by APOE ε4 status.
Lawal R et al. · Nutrients (2026)
Nutritional biomarkers appear to influence cognitive trajectories in MCI, and some associations may differ by APOE ε4 status.
However, small samples and limited genetic stratification constrain interpretation.
Future research should prioritise standardised biomarker measurement, genetically stratified cohorts, and individual participant data meta-analyses to clarify nutrient-gene interactions in MCI.
18Cognitive function improvementRCTCited 1×n=70 · small study2025
Supplementation of MCT, DHA and their combination for 12 months can significantly improve cognitive function, mitochondria function and increase serum total ketone body levels in MCI individuals.
Duan H et al. · Journal of affective disorders (2025)
Supplementation of MCT, DHA and their combination for 12 months can significantly improve cognitive function, mitochondria function and increase serum total ketone body levels in MCI individuals.
Combined intervention was more beneficial than MCT or DHA alone.
19Quality of life improvements in rheumatoid arthritisRCTn=61 · small study2026
Patients with RA supplemented with MCTs obtained significant improvements in several health-related QOL components compared to control, and fibre inclusion did not interfere with MCT efficacy.
Gaudioso G et al. · RMD open (2026)
After 16 weeks, the test group showed statistically and clinically significant improvements both in mental and physical health-related scores.
Regular intake of MCTs significantly reduced the intensity and duration of morning stiffness and pain intensity (assessed using the Visual Analogue Scale) from baseline to T4 compared with control group.
Patients with RA supplemented with MCTs obtained significant improvements in several health-related QOL components compared to control, and fibre inclusion did not interfere with MCT efficacy.
Conclusions: Within the context of the current study, the ingestion of sMLCT did not significantly influence the rate of muscle strength recovery following muscle damaging resistance exercise.
Velasquez CM et al. · Nutrients (2025)
Results: No statistically significant condition × time interactions were noted for strength outcomes, although trends for condition × time interactions were present for torque over 25 ms (p = 0.06) and peak torque (p = 0.05).
The baseline (i.e., pre-exercise) assessments of muscle performance, size, and soreness were compared to assessments immediately following exercise and 24, 48, and 72 h post-exercise.
Similarly, no condition x time interactions were present for ultrasound echo intensity, the subjective ratings of soreness and pain, thigh circumference, leg volume, and vertical jump performance.